TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

NCT06297642 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the current status of the same target research and the company's overall layout in the field of tumors, the early termination was determined after full communication with the principal investigator of the group leader unit.

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.